KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Non-Current Deffered Revenue (2017 - 2018)

Gsk (GSK) has 1 years of Non-Current Deffered Revenue data on record, last reported at $24.4 million in Q4 2018.

  • For Q4 2018, Non-Current Deffered Revenue changed N/A year-over-year to $24.4 million; the TTM value through Dec 2018 reached $24.4 million, changed N/A, while the annual FY2018 figure was $25.4 million, N/A changed from the prior year.
  • Non-Current Deffered Revenue reached $24.4 million in Q4 2018 per GSK's latest filing.
  • Across five years, Non-Current Deffered Revenue topped out at $24.4 million in Q4 2018 and bottomed at $24.4 million in Q4 2018.